Menopause Position Statements

Menopause Position Statements

“If you would like to find out what menopause
position statements are applicable to you, it may be
in your best interest to choose to talk to your…”.Meno Martha

Umbrella

What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Papers

Date

What can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics A-Z related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

BMS   = British Menopause Society
EMAS = European Menopause and Andropause Society
IGCS  = International Gynecologic Cancer Society
IMS    = International Menopause Society

New or Updated

  1. BMS Consensus Statements
  2. BMS Guidelines
  3. BMS Statement on Testosterone
  4. BMS Tools for Clinicians
  5. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  6. Bioidentical HRT [British Menopause Society]
  7. British Gynaecological Cancer Society (BGCS) Ovarian, Tubal and Primary Peritoneal Cancer Guidelines: Recommendations for Practice Update 2024
  8. British Gynaecological Cancer Society and British Menopause Society Guidelines Management of Menopausal Symptoms Following Treatment of Gynaecological Cancer
  9. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  10. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  11. Cardiovascular Risk Assessment In Women – An Update
  12. Chronic Kidney Disease and Menopausal Health: An EMAS Clinical Guide
  13. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  14. Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020 [Indian Menopause Society]
  15. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  16. Consumer Video and Podcast Series: 2023 Consumer Videos and Podcasts – NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms
  17. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  18. Drug Holidays From Bisphosphonates and Denosumab In Postmenopausal Osteoporosis
  19. EMAS On-Demand Webinars [European Menopause and Andropause Society] [Multiply Languages]: Genitourinary Syndrome of Menopause (GSM): Guidelines, Clinical Insights, and Real-World Practice
  20. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  21. EMAS Position Statement: Thyroid Disease and Menopause
  22. EMAS Position Statement: Vitamin D and Menopausal Health
  23. Eligibility Criteria for the Use Menopausal Hormone Therapy (MHT) In Women With Medical Conditions (II): Endometriosis, Neurological and Autoimmune Diseases
  24. Endometriosis and Menopausal Health: An EMAS Clinical Guide
  25. European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause
  26. Genitourinary Syndrome of Menopause (GSM) [November 2025]
  27. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
  28. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
  29. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  30. Global Consensus Statement on Menopausal Hormone Therapy
  31. Guideline on Premature Ovarian Insufficiency
  32. Guidelines and Education: EMAS Position Statements
  33. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  34. HRT and the Likelihood of Some Medical Conditions. A Discussion Aid for GPs and Patients. Menopause: Identification and Management (NICE Guideline NG23)
  35. ‘Healthy Menopause’: The European Menopause and Andropause Society (EMAS) 2026 Framework for Precision, Digital, and Interdisciplinary Midlife Health
    Menopause Position Statements
  36. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  37. Info for Professionals: Clinical Practice Guidelines [Indian Menopause Society]
  38. International Menopause Society (IMS) Recommendations and Key Messages on Women’s Midlife Health and Menopause
  39. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  40. Joint BMS BSGE BGCS FSRH GIRFT and RCOG Guideline on Management of Unscheduled Bleeding on HRT
  41. Joint BMS, FSRH, RCGP and RCOG Position Statement on the Supply Shortages of Hormone Replacement Therapy (HRT)
  42. Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  43. KKH MCHRI Launches Singapore’s First Set of Menopause Management Guidelines
  44. Learning From Sweden’s Experience In Menopause Care At the Global Level
  45. Making Menopause Work
  46. Management of Menopausal Symptoms Following Treatment of Gynecological Cancer
  47. Management of Menopause for Women With Cardiovascular Disease
  48. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  49. Management of Postmenopausal Women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines
  50. Management of Unscheduled Bleeding on Hormone Replacement Therapy (HRT)
  51. Managing Sleep Disturbance During the Menopause Transition
  52. Measurement of Serum Estradiol In the Menopause Transition
  53. Menopausal ‘Brain Fog’ or Dementia?—A Practical Guide for Clinicians
  54. Menopause Knowledge and Education In Women Under 40: Results From An Online Survey
  55. Menopause and Diabetes: EMAS Clinical Guide
  56. Menopause and Hormone Therapy In Relation To Dietary Intake, Physical Activity, and Sleep, and Meeting Lifestyle Guidelines
  57. Menopause and MHT In 2024: Addressing the Key Controversies – An International Menopause Society White Paper
  58. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  59. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  60. Menopause, Wellbeing and Health: A Care Pathway From the European Menopause and Andropause Society
  61. Menopause: Identification and Management [NICE Guideline]
  62. Menopause: Identification and Management [NICE Guideline]
    Menopause Position Statements
  63. Modernising Menopause Counselling Guide
    Menopause Position Statements
  64. New FAQ Document – Joint Guideline on Management of Unscheduled Bleeding on HRT
  65. New Menopause Practice Standards
  66. New Toolkit Aims To Improve Menopause Care for Women From Minority Ethnic Communities
  67. Online Events [International Menopause Society]: CAMS Menopause Hour Webinars – Genitourinary Health [Council of Affiliated Menopause Societies]
  68. Online Events [International Menopause Society]: Past Webinars – 2025: Lifestyle Medicine
  69. Online Events [International Menopause Society]: Past Webinars – 2026: New IMS Recommendations: Diagnosis of Menopause, Including Stages of Reproductive Aging Workshop +10
  70. Online Events [International Menopause Society]: Past Webinars – 2026: New IMS Recommendations: Evidence-Based Management of Vasomotor Symptoms
  71. Online Events [International Menopause Society]: Past Webinars – 2026: New IMS Recommendations – Lifestyle, Diet, Exercise
  72. Online Events [International Menopause Society]: Past Webinars – 2026: New IMS Recommendations – Midlife Body Changes
  73. Online Events [International Menopause Society]: Past Webinars – 2026: New IMS Recommendations: Sexuality and Genitourinary Syndrome of Menopause
  74. Optimising the Menopause Transition: Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  75. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  76. Position Papers and Consensus Statements [International Menopause Society]
  77. Position Statements & Other Reports [North American Menopause Society]
  78. Position Statements [Australasian Menopause Society]
  79. Premature Ovarian Insufficiency [British Menopause Society]
  80. Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative
  81. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  82. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  83. RCGP, RCOG and BMS Position Statement on the Menopause
  84. Revised Global Consensus Statement on Menopausal Hormone Therapy
  85. Sexual Health and Wellbeing and the Menopause: An EMAS Clinical Guide
  86. Surgical Menopause: A Toolkit for Healthcare Professionals
  87. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  88. The 2022 Hormone Therapy Position Statement of The North American Menopause Society
  89. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society
  90. The 2023 Practitioner’s Toolkit for Managing Menopause
  91. The Essential Menopause Curriculum for Healthcare Professionals: A European Menopause and Andropause Society (EMAS) Position Statement
  92. The Mediterranean Diet and Menopausal Health: An EMAS Position Statement
  93. The Updated Practitioner’s Toolkit for Managing Menopause [+ Video]
  94. The Silence and the Stigma: Menopause In Canada
  95. The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy
  96. Update of the 2015 Evidence Based guideline on Premature Ovarian Insufficiency – Now Published [31 October 2024]
  97. Use of Incretin-Based Therapies In Women Using Hormone Replacement Therapy (HRT)
  98. World Menopause Day 2024: The IMS White Paper: Menopause and MHT In 2024: Addressing the Key Controversies [Multiply Languages]
  99. World Menopause Day 2025 [18 October]
    Menopause Position Statements Menopause Position Statements
  100. World Menopause Day 2025: The IMS White Paper: The Role of Lifestyle Medicine In Menopausal Health: A Review of Non-Pharmacologic Interventions [Multiply Languages]

Topic Last Updated: 15 August 2026 – Topic Last Reviewed: 15 August 2026
Print Friendly, PDF & Email
/by
Copyright © 2011 – 2026 Meno Martha®. All Rights Reserved. | The information provided on  Meno Martha, Meno Martha International Menopause Directory and/or menomartha.com is for informational or educational purposes only. It is not intended to substitute for or replace the medical advice, diagnosis or treatment of your qualified health care providers. | By using this service you accept Meno Martha International Menopause Directory’s Terms of Use which incorporate Meno Martha International Menopause Directory’s Links Policy. | Meno Martha® is a registered Trademark | Meno Martha International Menopause Directory® is a registered Trademark.
Meno Martha and/or Meno Martha International Menopause Directory do not sell, produce or endorse any products, services or content of any kind including pills or potions for ‘menopause symptom relief’. Please Contact Us if you see or receive any advertisements allegedly by, for or on behalf of Meno Martha and/or Meno Martha International Menopause Directory.